Analysis of clinicopathological characteristics and prognostic factors of early‐stage human epidermal growth factor receptor 2 (HER2)‐low breast cancer: Compared with HER2‐0 breast cancer
Abstract Purpose To investigate the clinicopathological characteristics and prognostic factors of early‐stage breast cancer (EBC) with human epidermal growth factor receptor 2 (HER2)‐low expression. Methods The clinicopathological data and follow‐up information of EBC patients with HER2‐low and HER2...
Main Authors: | Qian Wu, Fan Yang, YinHua Liu, Hong Zhang, Shuang Zhang, Ling Xin, Ling Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6571 |
Similar Items
-
Clinicopathological features and prognosis of patients with HER2-low breast cancer
by: Xin Yang, et al.
Published: (2023-09-01) -
Can HER2 1+ Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer
by: Lan Shu, et al.
Published: (2022-08-01) -
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
by: Hangcheng Xu, et al.
Published: (2022-06-01) -
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
by: Tong Wei, et al.
Published: (2023-02-01) -
HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
by: Atul Batra, et al.
Published: (2021-02-01)